Preclinical In-Vivo Imaging Market
Preclinical In- Vivo Imaging Market By Modality Type (Micro-CT, Micro-MRI, Micro-Ultrasound), And By Reagent (Preclinical CT Contrast Agents, Preclinical MRI Contrast Agents, Preclinical Nuclear Imaging Reagents) - Forecast Year 2024 – 2031
Healthcare // Diagnostic Imaging
The global preclinical
in vivo imaging solutions market is foreseen to grow at 5.9%, from USD 580.4 Million
in 2021 to USD 918.1 Million in 2029. Technological advancements in the field
of molecular imaging, increasing market demand for noninvasive small-animal
imaging techniques, growing number of public-private initiatives and funding to
support preclinical researches are the factors driving the growth of the global
preclinical in vivo imaging solutions market. However, strict regulations
governing preclinical research, significant installation and operational costs
associated with preclinical imaging modalities is anticipated to restrain the
market growth for the estimated period.
Market Definition
What is Preclinical In
Vivo Imaging Solutions?
Preclinical
imaging is the visualization of living animals for research purposes, such as
drug development. Imaging modalities have long been crucial to the researcher
in observing changes, either at the organ, tissue, cell, or molecular level, in
animals responding to physiological or environmental changes.
Research Scope
The report
provides market value for base year 2021 and a yearly forecast from 2022 to
2029 in terms of revenue (USD Million). Market for each segment is present on
North America, Europe, Asia Pacific, Latin America and Middle East & Africa
as well as regional basis for the above-mentioned forecast period.
Key industry
dynamics, regulatory scenario, major material dynamics and Preclinical In Vivo
Imaging Solutions future markets are analyzed to understand their impact on
demand for the forecast period. Growth rates have been estimated using
correlation, regression and time-series analysis.
Market Overview
Preclinical In
Vivo Imaging Solutions Market report also provide a thorough understanding of
the cutting-edge competitive analysis of the emerging market trends along with
the drivers, restraints, challenges, and opportunities in the Preclinical In
Vivo Imaging Solutions Market to offer worthwhile insights and current scenario
for making right decision. The report covers the prominent players in the
market with detailed SWOT analysis, financial overview, and key developments of
the products/services from the past three years. Moreover, the report also
offers a 360º outlook of the market through the competitive landscape of the
global industry player and helps the companies to garner Preclinical In Vivo
Imaging Solutions Market revenue by understanding the strategic growth
approaches.
Preclinical In
Vivo Imaging Solutions Market study by “Zettabyte Analytics” provides details
about the market dynamics affecting the market, Market scope, Market
segmentation and overlays shadow upon the leading market players highlighting
the favorable competitive landscape and trends prevailing over the years.
Market Segmentation
For the purpose
of this report, the global Preclinical In Vivo Imaging Solutions Market is
segmented on the basis of Modality Type, Reagent and region:
|
Modality Type |
|
|
Micro-CT |
|
|
Micro-MRI |
|
|
Micro-Ultrasound |
|
|
Nuclear Imaging Systems |
|
|
|
Micro-PET Systems |
|
|
Micro-Spect Systems |
|
|
Trimodality (Spect/PET/CT) Systems |
|
Optical Imaging Systems |
|
|
|
Bioluminescence/Fluorescence Imaging Systems |
|
|
Standalone Fluorescence Imaging Systems |
|
|
(Optical + X-Ray)/(Optical + CT) Systems |
|
Other Imaging Systems |
|
|
Reagent |
|
|
Preclinical CT Contrast Agents |
|
|
Preclinical MRI Contrast Agents |
|
|
Preclinical Nuclear Imaging Reagents |
|
|
|
Preclinical PET Tracers |
|
|
Preclinical Spect Probes |
|
Preclinical Optical Imaging Reagents |
|
|
|
Bioluminescent Imaging Reagents |
|
|
Fluorescent Imaging Reagents |
|
Preclinical Ultrasound Contrast Agents |
|
Modality Type Outlook:
On the basis of
Modality Type, the market is segmented into Micro-CT, Micro-MRI,
Micro-Ultrasound, Nuclear Imaging Systems, Optical Imaging Systems, Other
Imaging Systems. Further, Nuclear Imaging Systems is segmented into Micro-PET
Systems, Micro-Spect Systems, Trimodality (Spect/PET/CT) Systems. Further,
Optical Imaging Systems is segmented into Bioluminescence/Fluorescence Imaging
Systems, Standalone Fluorescence Imaging Systems, (Optical + X-Ray)/(Optical +
CT) Systems.
Figure 1 - Preclinical In Vivo Imaging Solutions
Market, By Modality Type (Market Size And Forecast By Value - USD Million, 2021
& 2029)
Reagent Outlook:
On the basis of
Reagent, the market is segmented into Preclinical CT Contrast Agents,
Preclinical MRI Contrast Agents, Preclinical Nuclear Imaging Reagents,
Preclinical Optical Imaging Reagents, Preclinical Ultrasound Contrast Agents. Further,
Preclinical Nuclear Imaging Reagents is segmented into Preclinical PET Tracers,
Preclinical Spect Probes. Further, Preclinical Optical Imaging Reagents is
segmented into Bioluminescent Imaging Reagents, Fluorescent Imaging Reagents.
Figure 2 - Preclinical In Vivo Imaging
Solutions Market, By Reagent (Market Size And Forecast By Value - USD Million,
2021 & 2029)
Regional Outlook (Revenue, USD million; 2021
& 2029)
|
Regional Outlook
(Revenue, USD million; 2018-2029) |
|
|
North America |
U.S. |
|
Canada |
|
|
Europe |
Germany |
|
U.K. |
|
|
France |
|
|
Spain |
|
|
Italy |
|
|
Rest of the Europe |
|
|
Asia Pacific |
India |
|
Japan |
|
|
China |
|
|
South Korea |
|
|
Australia |
|
|
Rest of Asia-Pacific |
|
|
Middle East & Africa |
UAE |
|
Saudi Arabia |
|
|
South Africa |
|
|
Rest of Middle East & Africa |
|
|
Latin America |
Brazil |
|
Mexico |
|
|
Argentina |
|
|
Rest of Latin America |
|
Figure 4 - Preclinical In Vivo Imaging
Solutions Market: Regional dynamics
Companies Considered And Profiled In This
Market Study
The players
operating in the market have undertaken several strategies related to the
market in the period 2019-2021. Some of the prominent players in the Preclinical
In Vivo Imaging Solutions Market include:
· Agilent
Technologies
· Aspect Imaging Ltd.
· Berthold
Technologies
· Biospace Lab S.A.
· Bruker Corporation
· Fujifilm Holdings
Corporation
· Li-Cor Biosciences
· Mediso Ltd.
· Milabs B.V.
· Miltenyi Biotec
GmbH
· MR Solutions Ltd.
· New England Biolabs
· Perkinelmer, Inc.
· Thermo Fisher
Scientific
· Trifoil Imaging
· UVP
· Vieworks
Global Preclinical In Vivo Imaging Solutions
Market Report Scope
|
Historical
data |
2018 - 2020 |
|
Base
year for estimation |
2021 |
|
Forecast
period |
2022 - 2029 |
|
Market
size value in 2022 |
USD XX Million |
|
Revenue
forecast in 2029 |
USD 918.1 Million |
|
Growth
Rate |
CAGR of 5.9%
from 2022 to 2029 |
|
Quantitative
units |
Revenue in USD Million/Billion & CAGR
from 2022 to 2029 |
|
Report
coverage |
Revenue
forecast, company share, competitive landscape, growth factors, and trends |
|
Segments
covered |
Modality Type, Reagent, Region |
|
Key
companies profiled |
Perkinelmer,
Inc., Bruker Corporation, Fujifilm Holdings Corporation |
|
Regional
Scope |
North America, Europe, Asia Pacific, Middle
East & Africa, Latin America |
|
Country
Scope |
U.S.,
Canada, Germany, U.K., France, Italy, Spain, India, Japan, China, Australia,
South Korea, Saudi Arabia, UAE, South Africa, Brazil, Mexico, Argentina |
|
Customization
scope |
Free report customization (equivalent to up
to 8 analysts’ working days) with purchase. Addition or alteration to
country, regional & segment scope. |
Modality Type Outlook (Revenue, USD Million/Billion;
2018-2029)
· Micro-CT
· Micro-MRI
· Micro-Ultrasound
· Nuclear Imaging
Systems
o Micro-PET Systems
o Micro-Spect Systems
o Trimodality
(Spect/PET/CT) Systems
· Optical Imaging
Systems
o Bioluminescence/Fluorescence
Imaging Systems
o Standalone
Fluorescence Imaging Systems
o (Optical +
X-Ray)/(Optical + CT) Systems
· Other Imaging
Systems
Reagent Outlook (Revenue, USD
Million/Billion; 2018-2029)
· Preclinical CT
Contrast Agents
· Preclinical MRI
Contrast Agents
· Preclinical Nuclear
Imaging Reagents
o Preclinical PET
Tracers
o Preclinical Spect
Probes
· Preclinical Optical
Imaging Reagents
o Bioluminescent
Imaging Reagents
o Fluorescent Imaging
Reagents
· Preclinical
Ultrasound Contrast Agents
Regional Outlook (Revenue, USD
Million/Billion; 2018-2029)
· North America
o U.S.
o Canada
· Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of the Europe
· Asia Pacific
o India
o Japan
o China
o South Korea
o Australia
o Rest of
Asia-Pacific
· Middle East &
Africa
o UAE
o Saudi Arabia
o South Africa
o Rest of Middle East
& Africa
· Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin
America
Key Benefits of the Report:
· Global, regional,
country, modality type, reagent, and market size and
their forecast from 2018-2029.
· Identification and
detailed analysis on key market dynamics, such as, drivers, restraints,
opportunities, and challenges influencing growth of the market
· Detailed analysis
on industry outlook with market specific PESTLE, and supply chain to better
understand the market and build expansion strategies
· Identification of
key market players and comprehensively analyze their market share and core
competencies, detailed financial positions, key products, and unique selling
points
· Analysis on key
players’ strategic initiatives and competitive developments, such as
Collaborations, mergers, and new product launches in the market
· Expert interviews
and their insights on market shift, current and future outlook, and factors
impacting vendors’ short term and long-term strategies
· Detailed insights on emerging regions, modality type, reagent, and options with qualitative and quantitative information and fact.
|
Chapter 1. Introduction |
|
|
1.1. Market Definition |
|
|
1.2. Research Scope |
|
|
1.2.1. Markets Covered |
|
|
1.2.2. Years Considered for Study |
|
|
Chapter 2. Research Methodology |
|
|
2.1. Research Sources |
|
|
2.1.1. Primary |
|
|
2.1.2. Secondary |
|
|
2.2. Market Size Estimation |
|
|
Chapter 3. Executive Summary |
|
|
3.1. Summary Snapshot Market Size and Forecast, 2018-2029 |
|
|
3.2. Preclinical In Vivo Imaging Solutions Market Share by Modality
Type, 2021 vs 2029 (USD Million) |
|
|
3.3. Preclinical In Vivo Imaging Solutions Market Share by Reagent,
2021 vs 2029 (USD Million) |
|
|
3.5. Preclinical In Vivo Imaging Solutions Market Share by Region,
2021 vs 2029 (USD Million) |
|
|
Chapter 4. Key Insights |
|
|
Chapter 5. Preclinical In Vivo Imaging
Solutions Market Segmentation & Impact Analysis |
|
|
5.1. Preclinical In Vivo Imaging Solutions Market Indicators Analysis |
|
|
5.1.1. Market Drivers Analysis |
|
|
5.1.1.1.
Technological Advancements in the Field of Molecular Imaging |
|
|
5.1.1.2. Increasing
Market Demand for Noninvasive Small-Animal Imaging Techniques |
|
|
5.1.1.3. Growing Number of Public-Private
Initiatives and Funding to Support Preclinical Researches |
|
|
5.1.2. Market Restraint Analysis |
|
|
5.1.2.1. Strict
Regulations Governing Preclinical Research |
|
|
5.2.
Regulatory Analysis |
|
|
5.2.1. North America |
|
|
5.2.1.1. U.S. |
|
|
5.2.1.2. Canada |
|
|
5.2.2. Europe |
|
|
5.2.3. Asia Pacific |
|
|
5.2.3.1. India |
|
|
5.2.3.2. Japan |
|
|
5.2.3.3. China |
|
|
5.3. Technological Insights |
|
|
5.4. COVID-19 Impact analysis on Preclinical In Vivo Imaging Solutions
Market |
|
|
5.5.
Porter’s Five Forces Analysis |
|
|
5.5.1. Bargaining Power of Buyers/Consumers |
|
|
5.5.2. Bargaining Power of Suppliers |
|
|
5.5.3. Threat of New Entrants |
|
|
5.5.4. Threat of Substitute Products |
|
|
5.5.5. Intensity of
Competitive Rivalry |
|
|
5.6. Competitive Metric Space Analysis |
|
|
Chapter 6. Preclinical In Vivo Imaging
Solutions Market, By Modality Type (Market Size and Forecast by Value - USD
Million, 2018 - 2029) |
|
|
6.1. Preclinical In Vivo Imaging Solutions Market, By Modality Type
(Market Size and Forecast by Value - USD Million, 2021 & 2029) |
|
|
6.1.1. Micro-CT |
|
|
6.1.1.1.
Micro-CT Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
6.1.1.2. Micro-CT Market Estimates and Forecast, By
Region, 2019-2029 (USD Million) |
|
|
6.1.2. Micro-MRI |
|
|
6.1.2.1. Micro-MRI
Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
6.1.2.2. Micro-MRI
Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
6.1.3. Micro-Ultrasound |
|
|
6.1.3.1.
Micro-Ultrasound Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
6.1.3.2.
Micro-Ultrasound Market Estimates and Forecast, By Region, 2019-2029 (USD
Million) |
|
|
6.1.4. Nuclear Imaging Systems |
|
|
6.1.4.1. Nuclear Imaging Systems Market Estimates
and Forecast, 2019-2029 (USD Million) |
|
|
6.1.4.2. Nuclear Imaging Systems Market Estimates
and Forecast, By Region, 2019-2029 (USD Million) |
|
|
6.1.4.3.
Micro-PET Systems |
|
|
6.1.4.3.1. Micro-PET Systems
Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
6.1.4.3.2.
Micro-PET Systems Market Estimates and Forecast, By Region, 2019-2029 (USD
Million) |
|
|
6.1.4.4. Micro-Spect Systems |
|
|
6.1.4.4.1. Micro-Spect Systems Market Estimates and Forecast, 2019-2029
(USD Million) |
|
|
6.1.4.4.2. Micro-Spect Systems Market Estimates and Forecast, By
Region, 2019-2029 (USD Million) |
|
|
6.1.4.5. Trimodality (Spect/PET/CT) Systems |
|
|
6.1.4.5.1. Trimodality
(Spect/PET/CT) Systems Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
6.1.4.5.2. Trimodality (Spect/PET/CT) Systems Market Estimates and
Forecast, By Region, 2019-2029 (USD Million) |
|
|
6.1.5. Optical Imaging Systems |
|
|
6.1.5.1. Optical
Imaging Systems Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
6.1.5.2. Optical Imaging
Systems Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
6.1.5.3. Bioluminescence/Fluorescence Imaging
Systems |
|
|
6.1.5.3.1.
Bioluminescence/Fluorescence Imaging Systems Market Estimates and
Forecast, 2019-2029 (USD Million) |
|
|
6.1.5.3.2. Bioluminescence/Fluorescence Imaging Systems Market
Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
6.1.5.4. Standalone Fluorescence Imaging Systems |
|
|
6.1.5.4.1. Standalone Fluorescence Imaging Systems Market Estimates
and Forecast, 2019-2029 (USD Million) |
|
|
6.1.5.4.2. Standalone Fluorescence Imaging Systems Market Estimates
and Forecast, By Region, 2019-2029 (USD Million) |
|
|
6.1.5.5. (Optical + X-Ray)/(Optical + CT) Systems |
|
|
6.1.5.5.1.
(Optical + X-Ray)/(Optical + CT) Systems Market Estimates and Forecast,
2019-2029 (USD Million) |
|
|
6.1.5.5.2. (Optical + X-Ray)/(Optical + CT) Systems Market Estimates
and Forecast, By Region, 2019-2029 (USD Million) |
|
|
6.1.6. Other Imaging Systems |
|
|
6.1.6.1. Other
Imaging Systems Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
6.1.6.2. Other
Imaging Systems Market Estimates and Forecast, By Region, 2019-2029 (USD
Million) |
|
|
Chapter 7. Preclinical In Vivo Imaging
Solutions Market, By Reagent (Market Size and Forecast by Value - USD
Million, 2018 - 2029) |
|
|
7.1. Preclinical In Vivo Imaging Solutions Market, By Reagent (Market
Size and Forecast by Value - USD Million, 2021 & 2029) |
|
|
7.1.1. Preclinical CT Contrast
Agents |
|
|
7.1.1.1. Preclinical CT Contrast Agents Market Estimates
and Forecast, 2019-2029 (USD Million) |
|
|
7.1.1.2. Preclinical CT Contrast Agents Market
Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
7.1.2. Preclinical MRI Contrast
Agents |
|
|
7.1.2.1. Preclinical MRI Contrast
Agents Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
7.1.2.2. Preclinical
MRI Contrast Agents Market Estimates and Forecast, By Region, 2019-2029 (USD
Million) |
|
|
7.1.3. Preclinical Nuclear
Imaging Reagents |
|
|
7.1.3.1. Preclinical
Nuclear Imaging Reagents Market Estimates and Forecast, 2019-2029 (USD
Million) |
|
|
7.1.3.2. Preclinical
Nuclear Imaging Reagents Market Estimates and Forecast, By Region, 2019-2029
(USD Million) |
|
|
7.1.3.3. Preclinical PET Tracers |
|
|
7.1.3.3.1. Preclinical PET Tracers
Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
7.1.3.3.2. Preclinical PET Tracers Market Estimates and Forecast, By
Region, 2019-2029 (USD Million) |
|
|
7.1.3.4. Preclinical Spect Probes |
|
|
7.1.3.4.1. Preclinical Spect Probes Market Estimates and Forecast,
2019-2029 (USD Million) |
|
|
7.1.3.4.2. Preclinical Spect Probes Market Estimates and Forecast, By
Region, 2019-2029 (USD Million) |
|
|
7.1.4. Preclinical Optical
Imaging Reagents |
|
|
7.1.4.1. Preclinical
Optical Imaging Reagents Market Estimates and Forecast, 2019-2029 (USD
Million) |
|
|
7.1.4.2. Preclinical
Optical Imaging Reagents Market Estimates and Forecast, By Region, 2019-2029
(USD Million) |
|
|
7.1.4.3. Bioluminescent Imaging Reagents |
|
|
7.1.4.3.1. Bioluminescent
Imaging Reagents Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
7.1.4.3.2. Bioluminescent Imaging Reagents Market Estimates and
Forecast, By Region, 2019-2029 (USD Million) |
|
|
7.1.4.4. Fluorescent Imaging Reagents |
|
|
7.1.4.4.1. Fluorescent Imaging Reagents Market Estimates and Forecast,
2019-2029 (USD Million) |
|
|
7.1.4.4.2. Fluorescent Imaging Reagents Market Estimates and Forecast,
By Region, 2019-2029 (USD Million) |
|
|
7.1.5. Preclinical Ultrasound
Contrast Agents |
|
|
7.1.5.1. Preclinical Ultrasound Contrast Agents
Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
7.1.5.2. Preclinical Ultrasound Contrast Agents
Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
Chapter 8. Preclinical In Vivo Imaging
Solutions Market, By Region (Market Size and Forecast by Value - USD Million,
2018 - 2029) |
|
|
8.1. Preclinical In Vivo Imaging Solutions Market, By Region (Market
Size and Forecast by Value - USD Million, 2021 & 2029) |
|
|
8.2. North America |
|
|
8.2.1. North America
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million) |
|
|
8.2.2. North America
Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD
Million) |
|
|
8.2.3. North America
Preclinical In Vivo Imaging Solutions Market, By Country, 2018-2029 (USD
Million) |
|
|
8.2.4. U.S. |
|
|
8.2.4.1. U.S.
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million) |
|
|
8.2.4.2. U.S.
Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD
Million) |
|
|
8.2.5. Canada |
|
|
8.2.5.1. Canada
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million) |
|
|
8.2.5.2. Canada
Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD
Million) |
|
|
8.3. Europe |
|
|
8.3.1. Europe Preclinical In
Vivo Imaging Solutions Market, By Modality Type, 2018-2029 (USD Million) |
|
|
8.3.2. Europe Preclinical In
Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD Million) |
|
|
8.3.3. Europe Preclinical In
Vivo Imaging Solutions Market, By Country, 2018-2029 (USD Million) |
|
|
8.3.4. Germany |
|
|
8.3.4.1. Germany
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million) |
|
|
8.3.4.2. Germany
Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD
Million) |
|
|
8.3.5. U.K. |
|
|
8.3.5.1. U.K.
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million) |
|
|
8.3.5.2. U.K.
Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD
Million) |
|
|
8.3.6. France |
|
|
8.3.6.1. France
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million) |
|
|
8.3.6.2. France Preclinical
In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD Million) |
|
|
8.3.7. Spain |
|
|
8.3.7.1. Spain
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million) |
|
|
8.3.7.2. Spain
Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD
Million) |
|
|
8.3.8. Italy |
|
|
8.3.8.1. Italy
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million) |
|
|
8.3.8.2. Italy
Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD
Million) |
|
|
8.3.9. Rest of Europe |
|
|
8.3.9.1. Rest of
Europe Preclinical In Vivo Imaging Solutions Market, By Modality Type,
2018-2029 (USD Million) |
|
|
8.3.9.2. Rest of Europe
Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD
Million) |
|
|
8.4. Asia Pacific |
|
|
8.4.1. Asia Pacific Preclinical
In Vivo Imaging Solutions Market, By Modality Type, 2018-2029 (USD Million) |
|
|
8.4.2. Asia Pacific Preclinical
In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD Million) |
|
|
8.4.3. Asia Pacific Preclinical
In Vivo Imaging Solutions Market, By Country, 2018-2029 (USD Million) |
|
|
8.4.4. India |
|
|
8.4.4.1. India
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million) |
|
|
8.4.4.2. India
Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD
Million) |
|
|
8.4.5. Japan |
|
|
8.4.5.1. Japan
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million) |
|
|
8.4.5.2. Japan
Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD
Million) |
|
|
8.4.6. China |
|
|
8.4.6.1. China
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million) |
|
|
8.4.6.2. China
Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD
Million) |
|
|
8.4.7. South Korea |
|
|
8.4.7.1. South
Korea Preclinical In Vivo Imaging Solutions Market, By Modality Type,
2018-2029 (USD Million) |
|
|
8.4.7.2. South Korea
Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD
Million) |
|
|
8.4.8. Australia |
|
|
8.4.8.1.
Australia Preclinical In Vivo Imaging Solutions Market, By Modality Type,
2018-2029 (USD Million) |
|
|
8.4.8.2.
Australia Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029
(USD Million) |
|
|
8.4.9. Rest of Asia Pacific |
|
|
8.4.9.1. Rest of
Asia Pacific Preclinical In Vivo Imaging Solutions Market, By Modality Type,
2018-2029 (USD Million) |
|
|
8.4.9.2. Rest of
Asia Pacific Preclinical In Vivo Imaging Solutions Market, By Reagent,
2018-2029 (USD Million) |
|
|
8.5. Middle East & Africa |
|
|
8.5.1. Middle East & Africa
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million) |
|
|
8.5.2. Middle East &
AfricaPreclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029
(USD Million) |
|
|
8.5.3. Middle East & Africa
Preclinical In Vivo Imaging Solutions Market, By Country, 2018-2029 (USD
Million) |
|
|
8.5.4. UAE |
|
|
8.5.4.1. UAE
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million) |
|
|
8.5.4.2. UAE
Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD
Million) |
|
|
8.5.5. Saudi Arabia |
|
|
8.5.5.1. Saudi
Arabia Preclinical In Vivo Imaging Solutions Market, By Modality Type,
2018-2029 (USD Million) |
|
|
8.5.5.2. Saudi Arabia
Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD
Million) |
|
|
8.5.6. South Africa |
|
|
8.5.6.1. South
Africa Preclinical In Vivo Imaging Solutions Market, By Modality Type,
2018-2029 (USD Million) |
|
|
8.5.6.2. South
Africa Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029
(USD Million) |
|
|
8.5.7. Rest of Middle East
& Africa |
|
|
8.5.7.1. Rest of
Middle East & Africa Preclinical In Vivo Imaging Solutions Market, By
Modality Type, 2018-2029 (USD Million) |
|
|
8.5.7.2. Rest of
Middle East & Africa Preclinical In Vivo Imaging Solutions Market, By
Reagent, 2018-2029 (USD Million) |
|
|
8.6. Latin America |
|
|
8.6.1. Latin America
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million) |
|
|
8.6.2. Latin America Preclinical
In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD Million) |
|
|
8.6.3. Latin America
Preclinical In Vivo Imaging Solutions Market, By Country, 2018-2029 (USD
Million) |
|
|
8.6.4. Brazil |
|
|
8.6.4.1. Brazil Preclinical In Vivo
Imaging Solutions Market, By Modality Type, 2018-2029 (USD Million) |
|
|
8.6.4.2. Brazil
Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD
Million) |
|
|
8.6.5. Mexico |
|
|
8.6.5.1. Mexico
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million) |
|
|
8.6.5.2. Mexico Preclinical
In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD Million) |
|
|
8.6.6. Argentina |
|
|
8.6.6.1. Argentina
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million) |
|
|
8.6.6.2.
Argentina Preclinical In Vivo Imaging Solutions Market, By Reagent, 2018-2029
(USD Million) |
|
|
8.6.7. Rest of Latin America |
|
|
8.6.7.1. Rest of
Latin America Preclinical In Vivo Imaging Solutions Market, By Modality Type,
2018-2029 (USD Million) |
|
|
8.6.7.2. Rest of
Latin America Preclinical In Vivo Imaging Solutions Market, By Reagent,
2018-2029 (USD Million) |
|
|
Chapter 9. Competitive Landscape |
|
|
9.1. Market Revenue Share by Manufacturers |
|
|
9.2. Competitor’s Positioning |
|
|
9.3. Strategy Benchmarking |
|
|
9.3.1. Partnership &
Agreement |
|
|
9.3.2. New Product Development |
|
|
9.3.3. Mergers &
Acquisitions |
|
|
9.3.4. Investment &
Expansion |
|
|
9.4. Vendor Landscape |
|
|
9.4.1. Distributors |
|
|
9.4.2. North America |
|
|
9.4.3. Europe |
|
|
9.4.4. Asia Pacific |
|
|
9.4.5. Middle East &
Africa |
|
|
9.4.6. Latin America |
|
|
9.5. Zettabyte Analytics Insights for Competitive Landscape |
|
|
Chapter 10. Company Profiles |
|
|
10.1. Agilent Technologies |
|
|
10.1.1. Company Overview |
|
|
10.1.2. Financials |
|
|
10.1.3. Products Offered |
|
|
10.1.4. Recent
Development |
|
|
10.2.
Aspect Imaging Ltd. |
|
|
10.2.1. Company Overview |
|
|
10.2.2. Financials |
|
|
10.2.3. Products Offered |
|
|
10.2.4. Recent
Development |
|
|
10.3. Berthold Technologies |
|
|
10.3.1. Company Overview |
|
|
10.3.2. Financials |
|
|
10.3.3. Products Offered |
|
|
10.3.4. Recent
Development |
|
|
10.4. Biospace Lab S.A. |
|
|
10.4.1. Company Overview |
|
|
10.4.2. Financials |
|
|
10.4.3. Products Offered |
|
|
10.4.4. Recent
Development |
|
|
10.5. Bruker Corporation |
|
|
10.5.1. Company Overview |
|
|
10.5.2. Financials |
|
|
10.5.3. Products Offered |
|
|
10.5.4. Recent
Development |
|
|
10.6. Fujifilm Holdings Corporation |
|
|
10.6.1. Company Overview |
|
|
10.6.2. Financials |
|
|
10.6.3. Products Offered |
|
|
10.6.4. Recent
Development |
|
|
10.7. Li-Cor Biosciences |
|
|
10.7.1. Company Overview |
|
|
10.7.2. Financials |
|
|
10.7.3. Products Offered |
|
|
10.7.4. Recent
Development |
|
|
10.8.
Mediso Ltd. |
|
|
10.8.1. Company Overview |
|
|
10.8.2. Financials |
|
|
10.8.3. Products Offered |
|
|
10.8.4. Recent
Development |
|
|
10.9. Milabs B.V. |
|
|
10.9.1. Company Overview |
|
|
10.9.2. Financials |
|
|
10.9.3. Products Offered |
|
|
10.9.4. Recent
Development |
|
|
10.10. Miltenyi Biotec GmbH |
|
|
10.10.1. Company Overview |
|
|
10.10.2. Financials |
|
|
10.10.3. Products Offered |
|
|
10.10.4. Recent
Development |
|
|
10.11. MR Solutions Ltd. |
|
|
10.11.1. Company Overview |
|
|
10.11.2. Financials |
|
|
10.11.3. Products Offered |
|
|
10.11.4. Recent
Development |
|
|
10.12. New England Biolabs |
|
|
10.12.1. Company Overview |
|
|
10.12.2. Financials |
|
|
10.12.3. Products Offered |
|
|
10.12.4. Recent
Development |
|
|
10.13. Perkinelmer, Inc. |
|
|
10.13.1. Company Overview |
|
|
10.13.2. Financials |
|
|
10.13.3. Products Offered |
|
|
10.13.4. Recent
Development |
|
|
10.14. Thermo Fisher Scientific |
|
|
10.14.1. Company Overview |
|
|
10.14.2. Financials |
|
|
10.14.3. Products Offered |
|
|
10.14.4. Recent
Development |
|
|
10.15. Trifoil Imaging |
|
|
10.15.1. Company Overview |
|
|
10.15.2. Financials |
|
|
10.15.3. Products Offered |
|
|
10.15.4. Recent
Development |
|
|
10.16. UVP |
|
|
10.16.1. Company Overview |
|
|
10.16.2. Financials |
|
|
10.16.3. Products Offered |
|
|
10.16.4. Recent Development |
|
|
10.17. Vieworks |
|
|
10.17.1. Company Overview |
|
|
10.17.2. Financials |
|
|
10.17.3. Products Offered |
|
|
10.17.4. Recent
Development |
|
|
List of Tables |
|
|
1 |
Preclinical In Vivo Imaging Solutions
Market, By Modality Type (Market Size and Forecast by Value - USD Million,
2021 & 2029) |
|
2 |
Micro-CT Market Estimates and Forecast,
2019-2029 (USD Million) |
|
3 |
Micro-CT Market Estimates and Forecast, By
Region, 2019-2029 (USD Million) |
|
4 |
Micro-MRI Market Estimates and Forecast,
2019-2029 (USD Million) |
|
5 |
Micro-MRI Market Estimates and Forecast, By
Region, 2019-2029 (USD Million) |
|
6 |
Micro-Ultrasound Market Estimates and
Forecast, 2019-2029 (USD Million) |
|
7 |
Micro-Ultrasound Market Estimates and
Forecast, By Region, 2019-2029 (USD Million) |
|
8 |
Preclinical In Vivo Imaging Solutions
Market, By Reagent (Market Size and Forecast by Value - USD Million, 2021
& 2029) |
|
9 |
Preclinical CT Contrast Agents Market
Estimates and Forecast, 2019-2029 (USD Million) |
|
10 |
Preclinical CT Contrast Agents Market
Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
11 |
Preclinical MRI Contrast Agents Market
Estimates and Forecast, 2019-2029 (USD Million) |
|
12 |
Preclinical MRI Contrast Agents Market
Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
13 |
Preclinical Nuclear Imaging Reagents Market
Estimates and Forecast, 2019-2029 (USD Million) |
|
14 |
Preclinical Nuclear Imaging Reagents Market
Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
15 |
North America Preclinical In Vivo Imaging
Solutions Market, By Modality Type, 2018-2029 (USD Million) |
|
16 |
North America Preclinical In Vivo Imaging
Solutions Market, By Reagent, 2018-2029 (USD Million) |
|
17 |
North America Preclinical In Vivo Imaging
Solutions Market, By Country, 2018-2029 (USD Million) |
|
18 |
U.S. Preclinical In Vivo Imaging Solutions
Market, By Modality Type, 2018-2029 (USD Million) |
|
19 |
U.S. Preclinical In Vivo Imaging Solutions
Market, By Reagent, 2018-2029 (USD Million) |
|
20 |
Canada Preclinical In Vivo Imaging
Solutions Market, By Modality Type, 2018-2029 (USD Million) |
|
21 |
Canada Preclinical In Vivo Imaging
Solutions Market, By Reagent, 2018-2029 (USD Million) |
|
22 |
Europe Preclinical In Vivo Imaging
Solutions Market, By Modality Type, 2018-2029 (USD Million) |
|
23 |
Europe Preclinical In Vivo Imaging
Solutions Market, By Reagent, 2018-2029 (USD Million) |
|
24 |
Europe Preclinical In Vivo Imaging
Solutions Market, By Country, 2018-2029 (USD Million) |
|
25 |
Germany Preclinical In Vivo Imaging
Solutions Market, By Modality Type, 2018-2029 (USD Million) |
|
26 |
Germany Preclinical In Vivo Imaging
Solutions Market, By Reagent, 2018-2029 (USD Million) |
|
27 |
U.K. Preclinical In Vivo Imaging Solutions
Market, By Modality Type, 2018-2029 (USD Million) |
|
28 |
U.K. Preclinical In Vivo Imaging Solutions
Market, By Reagent, 2018-2029 (USD Million) |
|
29 |
France Preclinical In Vivo Imaging
Solutions Market, By Modality Type, 2018-2029 (USD Million) |
|
30 |
France Preclinical In Vivo Imaging
Solutions Market, By Reagent, 2018-2029 (USD Million) |
|
31 |
Spain Preclinical In Vivo Imaging Solutions
Market, By Modality Type, 2018-2029 (USD Million) |
|
32 |
Spain Preclinical In Vivo Imaging Solutions
Market, By Reagent, 2018-2029 (USD Million) |
|
33 |
Italy Preclinical In Vivo Imaging Solutions
Market, By Modality Type, 2018-2029 (USD Million) |
|
34 |
Italy Preclinical In Vivo Imaging Solutions
Market, By Reagent, 2018-2029 (USD Million) |
|
35 |
Rest of Europe Preclinical In Vivo Imaging
Solutions Market, By Modality Type, 2018-2029 (USD Million) |
|
36 |
Rest of Europe Preclinical In Vivo Imaging
Solutions Market, By Reagent, 2018-2029 (USD Million) |
|
37 |
Rest of Europe Preclinical In Vivo Imaging
Solutions Market, By , 2018-2029 (USD Million) |
|
38 |
Asia Pacific Preclinical In Vivo Imaging
Solutions Market, By Modality Type, 2018-2029 (USD Million) |
|
39 |
Asia Pacific Preclinical In Vivo Imaging
Solutions Market, By Reagent, 2018-2029 (USD Million) |
|
40 |
Asia Pacific Preclinical In Vivo Imaging
Solutions Market, By , 2018-2029 (USD Million) |
|
41 |
Asia Pacific Preclinical In Vivo Imaging
Solutions Market, By Country, 2018-2029 (USD Million) |
|
42 |
India Preclinical In Vivo Imaging Solutions
Market, By Modality Type, 2018-2029 (USD Million) |
|
43 |
India Preclinical In Vivo Imaging Solutions
Market, By Reagent, 2018-2029 (USD Million) |
|
44 |
Japan Preclinical In Vivo Imaging Solutions
Market, By Modality Type, 2018-2029 (USD Million) |
|
45 |
Japan Preclinical In Vivo Imaging Solutions
Market, By Reagent, 2018-2029 (USD Million) |
|
46 |
China Preclinical In Vivo Imaging Solutions
Market, By Modality Type, 2018-2029 (USD Million) |
|
47 |
China Preclinical In Vivo Imaging Solutions
Market, By Reagent, 2018-2029 (USD Million) |
|
48 |
South Korea Preclinical In Vivo Imaging
Solutions Market, By Modality Type, 2018-2029 (USD Million) |
|
49 |
South Korea Preclinical In Vivo Imaging
Solutions Market, By Reagent, 2018-2029 (USD Million) |
|
50 |
Australia Preclinical In Vivo Imaging
Solutions Market, By Modality Type, 2018-2029 (USD Million) |
|
51 |
Australia Preclinical In Vivo Imaging
Solutions Market, By Reagent, 2018-2029 (USD Million) |
|
52 |
Rest of Asia Pacific Preclinical In Vivo
Imaging Solutions Market, By Modality Type, 2018-2029 (USD Million) |
|
53 |
Rest of Asia Pacific Preclinical In Vivo
Imaging Solutions Market, By Reagent, 2018-2029 (USD Million) |
|
54 |
Middle East & Africa Preclinical In
Vivo Imaging Solutions Market, By Modality Type, 2018-2029 (USD Million) |
|
55 |
Middle East & AfricaPreclinical In Vivo
Imaging Solutions Market, By Reagent, 2018-2029 (USD Million) |
|
56 |
Middle East & Africa Preclinical In
Vivo Imaging Solutions Market, By Country, 2018-2029 (USD Million) |
|
57 |
UAE Preclinical In Vivo Imaging Solutions
Market, By Modality Type, 2018-2029 (USD Million) |
|
58 |
UAE Preclinical In Vivo Imaging Solutions
Market, By Reagent, 2018-2029 (USD Million) |
|
59 |
Saudi Arabia Preclinical In Vivo Imaging
Solutions Market, By Modality Type, 2018-2029 (USD Million) |
|
60 |
Saudi Arabia Preclinical In Vivo Imaging
Solutions Market, By Reagent, 2018-2029 (USD Million) |
|
61 |
South Africa Preclinical In Vivo Imaging
Solutions Market, By Modality Type, 2018-2029 (USD Million) |
|
62 |
South Africa Preclinical In Vivo Imaging
Solutions Market, By Reagent, 2018-2029 (USD Million) |
|
63 |
Rest of Middle East & Africa
Preclinical In Vivo Imaging Solutions Market, By Modality Type, 2018-2029
(USD Million) |
|
64 |
Rest of Middle East & Africa Preclinical
In Vivo Imaging Solutions Market, By Reagent, 2018-2029 (USD Million) |
|
65 |
Latin America Preclinical In Vivo Imaging
Solutions Market, By Modality Type, 2018-2029 (USD Million) |
|
66 |
Latin America Preclinical In Vivo Imaging
Solutions Market, By Reagent, 2018-2029 (USD Million) |
|
67 |
Latin America Preclinical In Vivo Imaging
Solutions Market, By Country, 2018-2029 (USD Million) |
|
68 |
Brazil Preclinical In Vivo Imaging
Solutions Market, By Modality Type, 2018-2029 (USD Million) |
|
69 |
Brazil Preclinical In Vivo Imaging
Solutions Market, By Reagent, 2018-2029 (USD Million) |
|
70 |
Mexico Preclinical In Vivo Imaging
Solutions Market, By Modality Type, 2018-2029 (USD Million) |
|
71 |
Mexico Preclinical In Vivo Imaging
Solutions Market, By Reagent, 2018-2029 (USD Million) |
|
72 |
Argentina Preclinical In Vivo Imaging
Solutions Market, By Modality Type, 2018-2029 (USD Million) |
|
73 |
Argentina Preclinical In Vivo Imaging
Solutions Market, By Reagent, 2018-2029 (USD Million) |
|
74 |
Rest of Latin America Preclinical In Vivo
Imaging Solutions Market, By Modality Type, 2018-2029 (USD Million) |
|
75 |
Rest of Latin America Preclinical In Vivo
Imaging Solutions Market, By Reagent, 2018-2029 (USD Million) |
|
76 |
Product Launch & Development in The
Preclinical In Vivo Imaging Solutions Market, 2018-2021 |
|
77 |
Recent Development in The Preclinical In
Vivo Imaging Solutions Market, 2018-2021 |
|
78 |
Partnership & Collaboration in The
Preclinical In Vivo Imaging Solutions Market, 2018-2021 |
|
79 |
Merger & Acquisition in The Preclinical
In Vivo Imaging Solutions Market, 2018-2021 |
|
List of Figures |
|
|
1 |
Research Methodology |
|
2 |
Summary Snapshot Market Size and Forecast,
USD Million, 2021 & 2029 |
|
3 |
Global Preclinical In Vivo Imaging
Solutions Market Segmentation & Impact Analysis |
|
4 |
Regulatory Analysis |
|
5 |
COVID-19 Impact analysis on Preclinical In
Vivo Imaging Solutions Market |
|
6 |
Market Revenue Share by Manufacturers |
|
7 |
Preclinical In Vivo Imaging Solutions
Market, By Modality Type (Market Size and Forecast by Value - USD Million,
2021 & 2029) |
|
8 |
Preclinical In Vivo Imaging Solutions
Market, By Reagent (Market Size and Forecast by Value - USD Million, 2021
& 2029) |
|
9 |
Preclinical In Vivo Imaging Solutions
Market, By Region (Market Size and Forecast by Value - USD Million, 2021
& 2029) |
1.
Research Sources
We at Zettabyte Analytics have a
detailed and related research methodology focussed on estimating the market
size and forecasted value for the given market. Comprehensive research
objectives and scope were obtained through secondary research of the parent and
peer markets. The next step was to validate our research by various market
models and primary research. Both top-down and bottom-up approaches were
employed to estimate the market. In addition to all the research reports, data
triangulation is one of the procedures used to evaluate the market size of
segments and sub-segments.
Research Methodology
1.1. Secondary Research
The secondary research study involves various sources and databases used
to analyze and collect information for the market-oriented survey of a specific
market. We use multiple databases for our exhaustive secondary research, such
as Factiva, Dun & Bradstreet, Bloomberg, Research article, Annual reports,
Press Release, and SEC filings of significant companies. Apart from this, a
dedicated set of teams continuously extracts data of key industry players and
makes an extensive and unique segmentation related to the latest market
development.
1.2. Primary Research
The primary research includes gathering data from specific domain
experts through a detailed questionnaire, emails, telephonic interviews, and
web-based surveys. The primary interviewees for this study include an expert
from the demand and supply side, such as CEOs, VPs, directors, sales heads, and
marketing managers of tire 1,2, and 3 companies across the globe.
1.3. Data Triangulation
The data triangulation is very important for any market study, thus we
at Zettabyte Analytics focus on at least three sources to ensure a high level
of accuracy. The data is triangulated by studying various factors and trends
from both supply and demand side. All the reports published and stored in our
repository follows a detailed process to obtain a reliable insight for our
clients.
1.4. In-House Verification
To validate the segmentation
and verify the data collected, our market expert ensures whether our research
analyst is considering fine distinction before analyzing the market.
1.5. Reporting
In the end,
presenting our research reports complied in a different format for straightforward
valuation such as ppt, pdf, and excel data pack is done.
+1 716 953 3077
sales@zettabyteanalytics.com
109 S Warren St, Syracuse, NY 13202, United States